Experimental facial myokymia in cat

Acta Neurologica Scandinavica

Volumn 95, Issue 1, 1997, Pages 19-22

  Zaaroor, M ^a   Starr, A ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

brainstem lesion; cat; glutamate; kainic acid; myokymia

Indexed keywords

KAINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; ELECTROMYOGRAM; FACIAL NERVE PARALYSIS; MYOKYMIA; NONHUMAN;

EID: 0031043914     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00062.x     Document Type: Article

References (20)

1. MATTEWS WB. Facial myokymia. J Neurol Neurosurg Psychiatry 1966: 29: 35-39.
2. GUTMANN L. Facial and limb myokymia. Muscle Nerve 1991: 14: 1043-1049.
3. JACOBS L, KABA S, PULLICINO P. The lesion causing continuos facial myokymia in multiple sclerosis. Arch Neurol 1994: 51: 1115-1119.
4. GILROY J, MEYER JS. Medical neurology. Macmillan: New York, 1975: 657-658.
5. WASSERSTROM WR, STARR A. Facial myokymia in the Guillain-Barré syndrome. Arch Neurol 1977: 34: 576-577.
6. SCAIOLI V, SAVOIARDO M, BUSSONE G, REZZONICO M. Brainstem auditory evoked potential (BAEPs) and magnetic resonance imaging (MRI) in case of facial myokymia. Electroencephalogr Clin Neurophysiol 1988: 71: 153-156.
7. ZAAROOR M, STARR A. Auditory brain-stem evoked potentials in cat after kainic acid induced neuronal loss. I. Superior olivary complex. Electroencephalogr Clin Neurophysiol 1991: 80: 422-435.
8. ZAAROOR M, STARR A. Auditory brain-stem evoked potentials in cat after kainic acid induced neuronal loss. II. Cochlear nucleus. Electroencephalogr Clin Neurophysiol 1991: 80: 436-445.
9. COYLE JT, MOLLIVER ME, KUHAR MJ. In situ injection of kainic acid: a new method for selectively lesioning neuronal cell bodies while sparing axons of passage. J Compr Neurol 1978: 180: 301-324.
10. MASTERTON RB, GLENDENNING KK, HUTSON KA. Preservation of trapezoid body fibers after biochemical ablation of superior olives with kainic acid. Brain Res 1979: 173: 156-159.
11. ROONEY BJ, KAVANAGH GL, KELLY JB. Preservation of fibers of passage following kainic acid lesions of the superior olivary complex in the ferret. An HRP analysis. Abstracts Society for Neuroscience. 18th annual meeting Toronto, Ont., 1988: 201.
12. SIVAK M, OSHOA J, FERNANDEZ J. Positive manifestation of nerve fiber dysfunction: Clinical electrophysiologic and pathologic correlates. In: Brown WF, Bolton CF, eds. Clinical electromyography, Second edition, Boston, Butterworth-Heinemann, 1993: 131-133.
13. FAROOQUI AA, HORROCKS LA. Excitatory amino acid receptors, neuronal membrane phospholipid metabolism and neurological disorders. Brain Res Rev 1991: 16: 171-191.
14. MAYER ML, WESTBROOK GL. The physiology of excitatory amino acids in the vertebrate central nerves system. Prog Neurobiol 1987: 28: 197-276.
15. ROTHMAN SM, OLNEY JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986: 19: 105-111.
16. MONAGHAN DT, BRIDGES RJ, COTMAN CW. The excitatory amino acid receptors: their classes pharmacology, and distinct properties in the function of the central nervous system, Annu Rev Pharmacol Toxicol 1989: 29: 365-402.
17. SMITH KJ, MCDONALD WI. Spontaneous and evoked electrical discharges from central demyelination lesion. J Neurol Sci 1982: 55: 39-47.
18. WAYBRIGHT EA, GUTMANN L, CHOU SM. Facial myokymia. Arch Neurol 1979: 36: 244-245.
19. CHERINGTON M, SADLER KM, RYAN D. Facial myokymia. Surg Neurol 1979: 11: 478-480.
20. SETHI PK, SMITH BH, KALYANARAMAN. Facial myokymia: a clinicopathological study. J Neurol Neurosurg Psychiatry 1974: 37: 745-759.